Nephrodite’s mission is to innovate and advance new solutions to address the global unmet need for better outcomes for patients with end-stage kidney disease. We are developing the Holly™, a fully implantable, mechanical, continuous hemodialysis device designed to be a bridge to transplant for eligible patients and/or a destination therapy for transplant ineligible patients.